data_1m3g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1m3g _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.22 0.533 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -172.97 -154.59 10.53 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 123.05 -92.19 0.46 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -59.15 145.77 96.62 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.621 1.327 . . . . 0.0 110.508 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.69 134.8 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.063 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.3 119.61 7.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.075 -1.016 . . . . 0.0 110.799 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.491 ' N ' ' CD1' ' A' ' 176' ' ' ILE . 1.9 mp -103.97 111.33 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.313 -0.867 . . . . 0.0 109.163 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.1 mt 54.38 174.85 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.567 -0.708 . . . . 0.0 110.307 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.45 2.26 7.93 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.596 1.313 . . . . 0.0 111.351 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -107.69 -37.71 6.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.856 -1.152 . . . . 0.0 110.857 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.48 HD21 ' CD2' ' A' ' 271' ' ' TYR . 1.8 mp -101.67 127.83 48.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.093 -1.004 . . . . 0.0 110.558 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.411 ' CE2' ' NE2' ' A' ' 195' ' ' GLN . 6.6 m-85 -128.74 146.41 50.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.15 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 268' ' ' CYS . 0.7 OUTLIER -143.05 150.28 39.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 110.628 -179.342 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -115.24 -160.58 12.77 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.2 t -172.23 -63.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -1.128 . . . . 0.0 110.295 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 63.4 m -110.8 -151.57 0.48 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.358 -0.839 . . . . 0.0 110.013 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 4.5 m -52.96 -22.54 5.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 110.424 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -58.58 -20.08 43.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 110.516 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 192' ' ' GLN . 7.0 m -68.69 -9.11 48.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 110.977 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.3 p -80.75 -66.45 0.88 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.951 -1.093 . . . . 0.0 110.135 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -58.24 -33.36 69.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.231 -0.918 . . . . 0.0 109.916 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.99 -64.17 0.99 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.831 . . . . 0.0 110.114 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.411 ' CB ' ' O ' ' A' ' 188' ' ' SER . 3.6 tt0 -52.81 -31.4 38.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 0.0 110.365 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -74.59 -52.05 7.67 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.39 -49.24 70.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.085 -1.244 . . . . 0.0 109.982 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.411 ' NE2' ' CE2' ' A' ' 181' ' ' PHE . 2.2 mm-40 -69.82 -33.48 72.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.347 -0.845 . . . . 0.0 109.952 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -51.37 -42.34 61.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.365 -0.834 . . . . 0.0 110.36 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' CYS . . . . . . . . . . . . . 2.4 m -54.39 -39.16 66.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.014 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -129.81 55.15 0.77 Allowed Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.52 163.9 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -1.1 . . . . 0.0 109.895 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 48.0 m -124.02 -61.68 1.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 110.087 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.47 121.93 44.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 0.0 110.179 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.34 110.86 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.059 -1.026 . . . . 0.0 110.624 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.456 ' CB ' ' HA ' ' A' ' 255' ' ' VAL . 2.2 mm? -78.71 76.21 5.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.366 -0.834 . . . . 0.0 110.557 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -68.56 90.86 0.4 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.364 -0.835 . . . . 0.0 110.64 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 29.7 m -69.85 78.5 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 110.39 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.34 -77.3 0.59 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 110.804 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -170.88 -143.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.154 -0.966 . . . . 0.0 110.389 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.8 t 60.5 22.75 12.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.02 -1.05 . . . . 0.0 110.448 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' CYS . . . . . 0.462 ' CB ' ' CD ' ' A' ' 210' ' ' PRO . 0.0 OUTLIER 50.29 -175.58 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 0.0 110.713 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 209' ' ' CYS . 28.6 Cg_exo -57.92 84.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.712 1.375 . . . . 0.0 110.462 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 209' ' ' CYS . 1.6 t-20 -97.86 144.92 26.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 110.297 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -116.49 74.4 0.9 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.456 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -86.64 -162.16 0.74 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -175.1 59.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 110.706 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -57.94 -37.0 83.36 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.3 pp -124.09 -23.48 4.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.324 -1.104 . . . . 0.0 110.765 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -168.56 -79.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.16 -0.963 . . . . 0.0 109.795 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -136.98 99.54 4.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.801 . . . . 0.0 109.881 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.74 112.9 25.0 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.18 -0.95 . . . . 0.0 110.373 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LYS . . . . . 0.483 ' HB3' ' CD2' ' A' ' 242' ' ' PHE . 6.7 mmtm -97.25 136.48 37.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.307 -0.87 . . . . 0.0 109.608 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.92 116.92 25.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.977 -1.077 . . . . 0.0 111.047 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 66.8 mt -98.76 135.0 21.14 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.746 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -68.56 115.64 4.01 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.359 1.189 . . . . 0.0 110.406 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 225' ' ' GLU . 94.0 t -99.02 168.31 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.916 . . . . 0.0 110.127 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.43 ' N ' HG12 ' A' ' 224' ' ' VAL . 13.8 mt-10 -121.51 -171.71 2.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.898 . . . . 0.0 110.501 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.79 68.32 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 110.293 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 229' ' ' MET . 10.9 t-20 -162.77 127.68 3.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 110.221 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 55.03 -87.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.443 -0.786 . . . . 0.0 110.475 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.433 ' N ' ' O ' ' A' ' 227' ' ' ASN . 0.6 OUTLIER -149.21 27.92 0.83 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.933 -1.105 . . . . 0.0 110.217 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.487 HG13 ' CH2' ' A' ' 235' ' ' TRP . 84.3 t 53.71 101.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.459 -0.775 . . . . 0.0 110.601 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -53.46 129.61 32.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.927 . . . . 0.0 110.104 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.441 ' CD1' ' HB ' ' A' ' 266' ' ' THR . 5.2 tt -101.15 16.93 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.891 . . . . 0.0 110.694 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.4 t -75.33 -5.58 45.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.172 -0.955 . . . . 0.0 110.836 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -100.45 -10.59 20.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.069 -1.019 . . . . 0.0 110.874 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.487 ' CH2' HG13 ' A' ' 230' ' ' VAL . 36.3 m0 -99.53 19.83 15.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.023 -1.048 . . . . 0.0 110.601 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.22 -65.84 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.034 -1.041 . . . . 0.0 109.676 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -64.48 -32.73 74.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 110.213 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -67.42 -49.36 64.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.24 -0.912 . . . . 0.0 110.038 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . 0.429 ' CB ' HG21 ' A' ' 267' ' ' ILE . . . -56.04 -58.76 6.54 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.379 -0.826 . . . . 0.0 111.037 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.43 ' CG2' ' HA ' ' A' ' 271' ' ' TYR . 1.0 OUTLIER -68.21 -16.68 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.98 . . . . 0.0 111.424 -178.123 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -87.73 -33.4 11.31 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.483 ' CD2' ' HB3' ' A' ' 220' ' ' LYS . 1.8 m-85 -82.41 -48.14 11.46 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.866 -0.785 . . . . 0.0 109.772 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.425 ' CD1' HG21 ' A' ' 253' ' ' VAL . 48.4 mm -65.78 -44.15 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.43 -0.793 . . . . 0.0 110.332 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 240' ' ' ILE . 57.1 t0 -68.65 -38.96 80.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.929 -1.107 . . . . 0.0 110.231 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TRP . . . . . 0.427 ' C ' ' CD1' ' A' ' 245' ' ' TRP . 9.6 t-105 -61.52 -28.3 69.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 110.025 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.4 t -81.2 -40.89 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.933 . . . . 0.0 110.548 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.77 -23.69 62.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.943 . . . . 0.0 110.459 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -88.08 -15.54 35.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 0.0 110.737 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 8.3 t -149.99 -49.68 0.14 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.144 -0.972 . . . . 0.0 110.494 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -54.25 -89.97 0.01 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 157.61 -72.63 0.24 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -123.25 130.11 52.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -1.11 . . . . 0.0 110.332 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.43 ' CG2' HD21 ' A' ' 203' ' ' LEU . 11.7 p -117.65 125.67 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 110.261 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.26 119.27 34.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 110.544 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.456 ' HA ' ' CB ' ' A' ' 203' ' ' LEU . 39.8 t -90.17 123.59 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.299 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -87.22 173.02 9.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.502 -0.749 . . . . 0.0 110.602 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 39.5 t -117.08 177.1 4.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 109.997 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.02 21.43 0.44 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 0.0 110.722 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -173.05 29.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 110.677 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 50.74 34.51 29.13 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.3 tt -117.79 170.4 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -1.125 . . . . 0.0 110.326 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 11.1 m -89.81 19.2 4.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 110.646 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . 0.418 ' NH1' ' CG2' ' A' ' 230' ' ' VAL . 10.3 ttm180 -51.95 -45.06 64.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.957 . . . . 0.0 110.309 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.428 ' HB3' ' CG1' ' A' ' 255' ' ' VAL . 4.5 m -60.86 -46.01 92.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.113 -0.992 . . . . 0.0 109.849 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . . . . . . . . . . . -60.6 -26.56 67.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.414 -0.804 . . . . 0.0 109.793 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' THR . . . . . 0.441 ' HB ' ' CD1' ' A' ' 232' ' ' ILE . 56.0 m -70.39 -38.96 74.78 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.374 -0.829 . . . . 0.0 109.642 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.44 HD11 ' CD1' ' A' ' 232' ' ' ILE . 42.6 mm -60.39 -53.96 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.154 -0.966 . . . . 0.0 109.295 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . 0.425 ' HB2' ' CD2' ' A' ' 182' ' ' LEU . 38.4 t -56.74 -31.66 64.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.19 -0.943 . . . . 0.0 109.363 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.429 ' CD1' ' HB2' ' A' ' 283' ' ' ALA . 0.3 OUTLIER -56.87 -47.01 81.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.366 -0.834 . . . . 0.0 109.352 178.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -57.44 -45.31 84.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.341 -0.85 . . . . 0.0 109.601 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . 0.48 ' CD2' HD21 ' A' ' 180' ' ' LEU . 68.0 t80 -54.28 -55.05 32.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.791 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 276' ' ' ARG . 0.1 OUTLIER -61.48 -18.84 60.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 110.428 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' MET . . . . . . . . . . . . . 20.9 mtm -85.04 -58.43 2.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.069 -1.019 . . . . 0.0 110.565 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -73.42 -23.93 60.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.456 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 271' ' ' TYR . 6.5 t -95.78 -48.26 5.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.597 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 272' ' ' LEU . 4.2 ttt-85 -92.09 -8.9 44.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 111.0 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 52.76 57.7 6.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.006 -1.059 . . . . 0.0 110.621 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 282' ' ' GLU . 28.5 m -124.22 5.88 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 110.878 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 55.68 165.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.278 -0.889 . . . . 0.0 110.77 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.465 ' CD1' ' CD2' ' A' ' 307' ' ' PHE . 1.8 tt -61.78 -16.59 50.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.205 -0.935 . . . . 0.0 110.378 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.21 -66.75 0.54 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.153 -0.967 . . . . 0.0 110.579 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLU . . . . . 0.414 ' HB3' ' HB ' ' A' ' 278' ' ' VAL . 1.4 tt0 -74.6 -30.62 61.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 110.22 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 269' ' ' LEU . . . -63.52 -55.14 26.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.178 -0.951 . . . . 0.0 109.964 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 288' ' ' LYS . 15.2 t80 -61.41 -33.07 73.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 110.171 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -72.97 -21.78 60.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 110.471 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.39 -49.84 6.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.905 . . . . 0.0 110.638 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.429 ' CG1' HD11 ' A' ' 176' ' ' ILE . 98.9 t -51.18 -25.24 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 110.717 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 284' ' ' PHE . 1.7 pttp -171.11 -171.28 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.084 -1.01 . . . . 0.0 110.586 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.6 -179.77 4.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 110.354 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -64.12 -154.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.25 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 54.58 95.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.103 -0.998 . . . . 0.0 110.372 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 145.78 72.85 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 56.2 t -109.26 128.33 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -1.144 . . . . 0.0 110.364 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 16.6 pt -91.67 149.39 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.893 . . . . 0.0 110.43 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 54.29 173.83 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.893 . . . . 0.0 110.528 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -63.88 99.8 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.602 1.317 . . . . 0.0 110.447 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -162.38 39.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 110.291 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -91.25 146.3 23.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 110.433 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 12.0 p 48.79 56.26 7.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.873 . . . . 0.0 110.765 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.73 136.42 16.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 110.286 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' MET . . . . . . . . . . . . . 27.6 mtt -124.46 45.59 2.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 110.278 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -95.26 -45.7 2.97 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -63.26 106.39 0.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -1.151 . . . . 0.0 110.502 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.83 -69.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 110.187 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.4 -22.15 66.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.915 . . . . 0.0 110.181 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.68 -63.47 1.21 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.875 . . . . 0.0 109.911 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' PHE . . . . . 0.465 ' CD2' ' CD1' ' A' ' 280' ' ' LEU . 1.3 m-85 -61.64 -34.53 75.86 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.342 -0.849 . . . . 0.0 109.901 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -56.09 -67.99 0.25 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.0 110.235 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 20.5 p -62.47 -13.73 33.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.091 -1.005 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -83.2 -45.81 13.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.011 -1.055 . . . . 0.0 110.999 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 12.0 p -96.98 -31.57 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 111.293 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . . . . . . . . . 2.4 mp -88.9 -74.37 0.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.947 -1.096 . . . . 0.0 110.386 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' CYS . . . . . . . . . . . . . 32.4 t -50.93 -49.71 59.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.591 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 65.7 m80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.403 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.22 0.533 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -172.97 -154.59 10.53 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 123.05 -92.19 0.46 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -59.15 145.77 96.62 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.621 1.327 . . . . 0.0 110.508 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.579 HG13 HG12 ' A' ' 287' ' ' VAL . 57.9 t -122.69 134.8 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.063 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.583 ' C ' HD12 ' A' ' 176' ' ' ILE . 0.4 OUTLIER -148.3 119.61 7.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.075 -1.016 . . . . 0.0 110.799 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.965 HD11 HG13 ' A' ' 287' ' ' VAL . 1.9 mp -103.97 111.33 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.313 -0.867 . . . . 0.0 109.163 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.1 mt 54.38 174.85 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.567 -0.708 . . . . 0.0 110.307 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.45 2.26 7.93 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.596 1.313 . . . . 0.0 111.351 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -107.69 -37.71 6.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.856 -1.152 . . . . 0.0 110.857 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.783 HD21 HG21 ' A' ' 243' ' ' ILE . 1.8 mp -101.67 127.83 48.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.093 -1.004 . . . . 0.0 110.558 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.453 ' CB ' HD12 ' A' ' 254' ' ' LEU . 6.6 m-85 -128.74 146.41 50.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.15 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.71 HD22 ' HA ' ' A' ' 265' ' ' ALA . 0.7 OUTLIER -143.05 150.28 39.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 110.628 -179.342 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -115.24 -160.58 12.77 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.2 t -172.23 -63.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -1.128 . . . . 0.0 110.295 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 63.4 m -110.8 -151.57 0.48 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.358 -0.839 . . . . 0.0 110.013 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 4.5 m -52.96 -22.54 5.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 110.424 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -58.58 -20.08 43.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 110.516 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 192' ' ' GLN . 7.0 m -68.69 -9.11 48.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 110.977 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.3 p -80.75 -66.45 0.88 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.951 -1.093 . . . . 0.0 110.135 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.522 ' O ' HD12 ' A' ' 194' ' ' LEU . 1.7 t70 -58.24 -33.36 69.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.231 -0.918 . . . . 0.0 109.916 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.99 -64.17 0.99 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.831 . . . . 0.0 110.114 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.679 ' O ' ' HB2' ' A' ' 196' ' ' ALA . 3.6 tt0 -52.81 -31.4 38.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 0.0 110.365 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 196' ' ' ALA . . . -74.59 -52.05 7.67 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 190' ' ' ASP . 0.2 OUTLIER -54.39 -49.24 70.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.085 -1.244 . . . . 0.0 109.982 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.424 ' HB3' HG12 ' A' ' 199' ' ' ILE . 2.2 mm-40 -69.82 -33.48 72.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.347 -0.845 . . . . 0.0 109.952 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 192' ' ' GLN . . . -51.37 -42.34 61.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.365 -0.834 . . . . 0.0 110.36 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' CYS . . . . . . . . . . . . . 2.4 m -54.39 -39.16 66.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.014 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -129.81 55.15 0.77 Allowed Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.424 HG12 ' HB3' ' A' ' 195' ' ' GLN . 0.3 OUTLIER -108.52 163.9 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -1.1 . . . . 0.0 109.895 -179.166 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 48.0 m -124.02 -61.68 1.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 110.087 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.501 ' HB3' HG11 ' A' ' 246' ' ' VAL . . . -104.47 121.93 44.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 0.0 110.179 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.505 HG21 HD21 ' A' ' 216' ' ' LEU . 59.8 t -107.34 110.86 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.059 -1.026 . . . . 0.0 110.624 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.671 HD23 ' CG2' ' A' ' 253' ' ' VAL . 2.2 mm? -78.71 76.21 5.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.366 -0.834 . . . . 0.0 110.557 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -68.56 90.86 0.4 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.364 -0.835 . . . . 0.0 110.64 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.556 ' O ' HG23 ' A' ' 205' ' ' VAL . 29.7 m -69.85 78.5 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 110.39 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.34 -77.3 0.59 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 110.804 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 223' ' ' PRO . . . -170.88 -143.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.154 -0.966 . . . . 0.0 110.389 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.8 t 60.5 22.75 12.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.02 -1.05 . . . . 0.0 110.448 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' CYS . . . . . 0.462 ' CB ' ' CD ' ' A' ' 210' ' ' PRO . 0.0 OUTLIER 50.29 -175.58 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 0.0 110.713 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 209' ' ' CYS . 28.6 Cg_exo -57.92 84.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.712 1.375 . . . . 0.0 110.462 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 209' ' ' CYS . 1.6 t-20 -97.86 144.92 26.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 110.297 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -116.49 74.4 0.9 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.456 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.409 ' HB3' ' HB3' ' A' ' 219' ' ' TYR . 0.7 OUTLIER -86.64 -162.16 0.74 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -175.1 59.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 110.706 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -57.94 -37.0 83.36 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' A' ' 217' ' ' PHE . 1.3 pp -124.09 -23.48 4.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.324 -1.104 . . . . 0.0 110.765 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.555 ' HB2' HD12 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -168.56 -79.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.16 -0.963 . . . . 0.0 109.795 179.455 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 2.5 mpt_? -136.98 99.54 4.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.801 . . . . 0.0 109.881 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.409 ' HB3' ' HB3' ' A' ' 213' ' ' PHE . 0.2 OUTLIER -91.74 112.9 25.0 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.18 -0.95 . . . . 0.0 110.373 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LYS . . . . . 0.494 ' HB3' ' CD2' ' A' ' 242' ' ' PHE . 6.7 mmtm -97.25 136.48 37.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.307 -0.87 . . . . 0.0 109.608 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.92 116.92 25.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.977 -1.077 . . . . 0.0 111.047 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 66.8 mt -98.76 135.0 21.14 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.746 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 207' ' ' ALA . 27.2 Cg_endo -68.56 115.64 4.01 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.359 1.189 . . . . 0.0 110.406 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 225' ' ' GLU . 94.0 t -99.02 168.31 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.916 . . . . 0.0 110.127 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.569 ' HB2' HG13 ' A' ' 230' ' ' VAL . 13.8 mt-10 -121.51 -171.71 2.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.898 . . . . 0.0 110.501 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.79 68.32 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 110.293 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 229' ' ' MET . 10.9 t-20 -162.77 127.68 3.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 110.221 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 55.03 -87.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.443 -0.786 . . . . 0.0 110.475 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.433 ' N ' ' O ' ' A' ' 227' ' ' ASN . 0.6 OUTLIER -149.21 27.92 0.83 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.933 -1.105 . . . . 0.0 110.217 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.611 HG21 ' NH1' ' A' ' 263' ' ' ARG . 84.3 t 53.71 101.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.459 -0.775 . . . . 0.0 110.601 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -53.46 129.61 32.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.927 . . . . 0.0 110.104 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.614 HG21 HG21 ' A' ' 266' ' ' THR . 5.2 tt -101.15 16.93 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.891 . . . . 0.0 110.694 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.4 t -75.33 -5.58 45.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.172 -0.955 . . . . 0.0 110.836 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -100.45 -10.59 20.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.069 -1.019 . . . . 0.0 110.874 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.767 ' HE3' HD11 ' A' ' 267' ' ' ILE . 36.3 m0 -99.53 19.83 15.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.023 -1.048 . . . . 0.0 110.601 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.22 -65.84 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.034 -1.041 . . . . 0.0 109.676 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -64.48 -32.73 74.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 110.213 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 235' ' ' TRP . 9.1 tm-20 -67.42 -49.36 64.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.24 -0.912 . . . . 0.0 110.038 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.679 ' CB ' HG23 ' A' ' 267' ' ' ILE . . . -56.04 -58.76 6.54 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.379 -0.826 . . . . 0.0 111.037 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.957 HG22 ' HA ' ' A' ' 271' ' ' TYR . 1.0 OUTLIER -68.21 -16.68 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.98 . . . . 0.0 111.424 -178.123 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 245' ' ' TRP . . . -87.73 -33.4 11.31 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.742 ' O ' HG23 ' A' ' 246' ' ' VAL . 1.8 m-85 -82.41 -48.14 11.46 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.866 -0.785 . . . . 0.0 109.772 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.939 HD13 HG21 ' A' ' 253' ' ' VAL . 48.4 mm -65.78 -44.15 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.43 -0.793 . . . . 0.0 110.332 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 240' ' ' ILE . 57.1 t0 -68.65 -38.96 80.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.929 -1.107 . . . . 0.0 110.231 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TRP . . . . . 0.427 ' CD1' ' C ' ' A' ' 245' ' ' TRP . 9.6 t-105 -61.52 -28.3 69.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 110.025 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 242' ' ' PHE . 71.4 t -81.2 -40.89 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.933 . . . . 0.0 110.548 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.77 -23.69 62.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.943 . . . . 0.0 110.459 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -88.08 -15.54 35.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 0.0 110.737 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 8.3 t -149.99 -49.68 0.14 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.144 -0.972 . . . . 0.0 110.494 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -54.25 -89.97 0.01 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 157.61 -72.63 0.24 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -123.25 130.11 52.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -1.11 . . . . 0.0 110.332 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.939 HG21 HD13 ' A' ' 243' ' ' ILE . 11.7 p -117.65 125.67 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 110.261 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.453 HD12 ' CB ' ' A' ' 181' ' ' PHE . 0.5 OUTLIER -118.26 119.27 34.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 110.544 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.558 HG12 ' HB3' ' A' ' 264' ' ' SER . 39.8 t -90.17 123.59 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.299 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -87.22 173.02 9.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.502 -0.749 . . . . 0.0 110.602 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 39.5 t -117.08 177.1 4.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 109.997 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.02 21.43 0.44 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 0.0 110.722 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -173.05 29.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 110.677 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 50.74 34.51 29.13 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 263' ' ' ARG . 11.3 tt -117.79 170.4 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -1.125 . . . . 0.0 110.326 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 11.1 m -89.81 19.2 4.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 110.646 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ARG . . . . . 0.611 ' NH1' HG21 ' A' ' 230' ' ' VAL . 10.3 ttm180 -51.95 -45.06 64.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.957 . . . . 0.0 110.309 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.558 ' HB3' HG12 ' A' ' 255' ' ' VAL . 4.5 m -60.86 -46.01 92.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.113 -0.992 . . . . 0.0 109.849 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.71 ' HA ' HD22 ' A' ' 182' ' ' LEU . . . -60.6 -26.56 67.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.414 -0.804 . . . . 0.0 109.793 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.614 HG21 HG21 ' A' ' 232' ' ' ILE . 56.0 m -70.39 -38.96 74.78 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.374 -0.829 . . . . 0.0 109.642 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.767 HD11 ' HE3' ' A' ' 235' ' ' TRP . 42.6 mm -60.39 -53.96 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.154 -0.966 . . . . 0.0 109.295 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' CYS . . . . . 0.703 ' SG ' HD23 ' A' ' 180' ' ' LEU . 38.4 t -56.74 -31.66 64.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.19 -0.943 . . . . 0.0 109.363 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.732 HD22 HG21 ' A' ' 287' ' ' VAL . 0.3 OUTLIER -56.87 -47.01 81.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.366 -0.834 . . . . 0.0 109.352 178.178 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -57.44 -45.31 84.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.341 -0.85 . . . . 0.0 109.601 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.957 ' HA ' HG22 ' A' ' 240' ' ' ILE . 68.0 t80 -54.28 -55.05 32.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.791 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.625 ' O ' HG22 ' A' ' 278' ' ' VAL . 0.1 OUTLIER -61.48 -18.84 60.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 110.428 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 273' ' ' MET . . . . . 0.405 ' SD ' HG11 ' A' ' 311' ' ' VAL . 20.9 mtm -85.04 -58.43 2.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.069 -1.019 . . . . 0.0 110.565 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.532 ' HB2' HG22 ' A' ' 311' ' ' VAL . 4.0 tm0? -73.42 -23.93 60.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.456 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 271' ' ' TYR . 6.5 t -95.78 -48.26 5.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.597 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 272' ' ' LEU . 4.2 ttt-85 -92.09 -8.9 44.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 111.0 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.426 ' HA ' HD21 ' A' ' 312' ' ' LEU . 2.8 mtt85 52.76 57.7 6.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.006 -1.059 . . . . 0.0 110.621 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.882 HG23 ' HB2' ' A' ' 283' ' ' ALA . 28.5 m -124.22 5.88 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 110.878 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 55.68 165.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.278 -0.889 . . . . 0.0 110.77 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.725 HD12 ' CD2' ' A' ' 307' ' ' PHE . 1.8 tt -61.78 -16.59 50.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.205 -0.935 . . . . 0.0 110.378 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.21 -66.75 0.54 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.153 -0.967 . . . . 0.0 110.579 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLU . . . . . 0.421 ' HB3' ' HB ' ' A' ' 278' ' ' VAL . 1.4 tt0 -74.6 -30.62 61.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 110.22 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.882 ' HB2' HG23 ' A' ' 278' ' ' VAL . . . -63.52 -55.14 26.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.178 -0.951 . . . . 0.0 109.964 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' PHE . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 288' ' ' LYS . 15.2 t80 -61.41 -33.07 73.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 110.171 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -72.97 -21.78 60.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 110.471 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.39 -49.84 6.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.905 . . . . 0.0 110.638 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.965 HG13 HD11 ' A' ' 176' ' ' ILE . 98.9 t -51.18 -25.24 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 110.717 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 284' ' ' PHE . 1.7 pttp -171.11 -171.28 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.084 -1.01 . . . . 0.0 110.586 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.6 -179.77 4.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 110.354 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -64.12 -154.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.25 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 54.58 95.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.103 -0.998 . . . . 0.0 110.372 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 145.78 72.85 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 56.2 t -109.26 128.33 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -1.144 . . . . 0.0 110.364 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 16.6 pt -91.67 149.39 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.893 . . . . 0.0 110.43 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 54.29 173.83 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.893 . . . . 0.0 110.528 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -63.88 99.8 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.602 1.317 . . . . 0.0 110.447 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -162.38 39.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 110.291 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -91.25 146.3 23.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 110.433 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 12.0 p 48.79 56.26 7.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.873 . . . . 0.0 110.765 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.73 136.42 16.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 110.286 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' MET . . . . . . . . . . . . . 27.6 mtt -124.46 45.59 2.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 110.278 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -95.26 -45.7 2.97 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -63.26 106.39 0.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -1.151 . . . . 0.0 110.502 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.83 -69.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 110.187 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.447 HD23 HG23 ' A' ' 309' ' ' THR . 0.6 OUTLIER -65.4 -22.15 66.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.915 . . . . 0.0 110.181 179.581 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.68 -63.47 1.21 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.875 . . . . 0.0 109.911 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' PHE . . . . . 0.725 ' CD2' HD12 ' A' ' 280' ' ' LEU . 1.3 m-85 -61.64 -34.53 75.86 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.342 -0.849 . . . . 0.0 109.901 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.413 ' HA ' HD13 ' A' ' 312' ' ' LEU . 26.1 tt0 -56.09 -67.99 0.25 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.0 110.235 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' THR . . . . . 0.447 HG23 HD23 ' A' ' 305' ' ' LEU . 20.5 p -62.47 -13.73 33.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.091 -1.005 . . . . 0.0 110.849 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -83.2 -45.81 13.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.011 -1.055 . . . . 0.0 110.999 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.829 HG13 HD12 ' A' ' 312' ' ' LEU . 12.0 p -96.98 -31.57 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 111.293 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.829 HD12 HG13 ' A' ' 311' ' ' VAL . 2.4 mp -88.9 -74.37 0.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.947 -1.096 . . . . 0.0 110.386 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' CYS . . . . . . . . . . . . . 32.4 t -50.93 -49.71 59.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.591 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 65.7 m80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.403 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.22 0.533 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -172.97 -154.59 10.53 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 123.05 -92.19 0.46 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -59.15 145.77 96.62 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.621 1.327 . . . . 0.0 110.508 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.579 HG13 HG12 ' A' ' 287' ' ' VAL . 57.9 t -122.69 134.8 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.063 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.583 ' C ' HD12 ' A' ' 176' ' ' ILE . 0.4 OUTLIER -148.3 119.61 7.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.075 -1.016 . . . . 0.0 110.799 -179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.965 HD11 HG13 ' A' ' 287' ' ' VAL . 1.9 mp -103.97 111.33 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.313 -0.867 . . . . 0.0 109.163 179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.1 mt 54.38 174.85 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.567 -0.708 . . . . 0.0 110.307 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.45 2.26 7.93 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.596 1.313 . . . . 0.0 111.351 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -107.69 -37.71 6.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.856 -1.152 . . . . 0.0 110.857 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.783 HD21 HG21 ' A' ' 243' ' ' ILE . 1.8 mp -101.67 127.83 48.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.093 -1.004 . . . . 0.0 110.558 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.453 ' CB ' HD12 ' A' ' 254' ' ' LEU . 6.6 m-85 -128.74 146.41 50.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.15 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.71 HD22 ' HA ' ' A' ' 265' ' ' ALA . 0.7 OUTLIER -143.05 150.28 39.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 110.628 -179.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -115.24 -160.58 12.77 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 9.2 t -172.23 -63.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -1.128 . . . . 0.0 110.295 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 63.4 m -110.8 -151.57 0.48 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.358 -0.839 . . . . 0.0 110.013 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 4.5 m -52.96 -22.54 5.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 110.424 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -58.58 -20.08 43.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 110.516 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 192' ' ' GLN . 7.0 m -68.69 -9.11 48.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 110.977 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 70.3 p -80.75 -66.45 0.88 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.951 -1.093 . . . . 0.0 110.135 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.522 ' O ' HD12 ' A' ' 194' ' ' LEU . 1.7 t70 -58.24 -33.36 69.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.231 -0.918 . . . . 0.0 109.916 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.99 -64.17 0.99 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.371 -0.831 . . . . 0.0 110.114 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.679 ' O ' ' HB2' ' A' ' 196' ' ' ALA . 3.6 tt0 -52.81 -31.4 38.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 0.0 110.365 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 196' ' ' ALA . . . -74.59 -52.05 7.67 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 190' ' ' ASP . 0.2 OUTLIER -54.39 -49.24 70.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.085 -1.244 . . . . 0.0 109.982 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.424 ' HB3' HG12 ' A' ' 199' ' ' ILE . 2.2 mm-40 -69.82 -33.48 72.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.347 -0.845 . . . . 0.0 109.952 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' A' ' 192' ' ' GLN . . . -51.37 -42.34 61.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.365 -0.834 . . . . 0.0 110.36 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' CYS . . . . . . . . . . . . . 2.4 m -54.39 -39.16 66.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.014 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -129.81 55.15 0.77 Allowed Glycine 0 N--CA 1.484 1.839 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.424 HG12 ' HB3' ' A' ' 195' ' ' GLN . 0.3 OUTLIER -108.52 163.9 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -1.1 . . . . 0.0 109.895 -179.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 48.0 m -124.02 -61.68 1.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 110.087 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.501 ' HB3' HG11 ' A' ' 246' ' ' VAL . . . -104.47 121.93 44.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 0.0 110.179 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.505 HG21 HD21 ' A' ' 216' ' ' LEU . 59.8 t -107.34 110.86 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.059 -1.026 . . . . 0.0 110.624 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.671 HD23 ' CG2' ' A' ' 253' ' ' VAL . 2.2 mm? -78.71 76.21 5.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.366 -0.834 . . . . 0.0 110.557 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -68.56 90.86 0.4 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.364 -0.835 . . . . 0.0 110.64 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.556 ' O ' HG23 ' A' ' 205' ' ' VAL . 29.7 m -69.85 78.5 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 110.39 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.34 -77.3 0.59 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.089 -1.007 . . . . 0.0 110.804 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 223' ' ' PRO . . . -170.88 -143.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.154 -0.966 . . . . 0.0 110.389 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.8 t 60.5 22.75 12.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.02 -1.05 . . . . 0.0 110.448 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' CYS . . . . . 0.462 ' CB ' ' CD ' ' A' ' 210' ' ' PRO . 0.0 OUTLIER 50.29 -175.58 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 0.0 110.713 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 209' ' ' CYS . 28.6 Cg_exo -57.92 84.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.712 1.375 . . . . 0.0 110.462 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 209' ' ' CYS . 1.6 t-20 -97.86 144.92 26.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 110.297 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -116.49 74.4 0.9 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 110.456 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.409 ' HB3' ' HB3' ' A' ' 219' ' ' TYR . 0.7 OUTLIER -86.64 -162.16 0.74 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -175.1 59.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 110.706 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -57.94 -37.0 83.36 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' A' ' 217' ' ' PHE . 1.3 pp -124.09 -23.48 4.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.324 -1.104 . . . . 0.0 110.765 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.555 ' HB2' HD12 ' A' ' 216' ' ' LEU . 0.7 OUTLIER -168.56 -79.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.16 -0.963 . . . . 0.0 109.795 179.455 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 2.5 mpt_? -136.98 99.54 4.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.419 -0.801 . . . . 0.0 109.881 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.409 ' HB3' ' HB3' ' A' ' 213' ' ' PHE . 0.2 OUTLIER -91.74 112.9 25.0 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.18 -0.95 . . . . 0.0 110.373 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LYS . . . . . 0.494 ' HB3' ' CD2' ' A' ' 242' ' ' PHE . 6.7 mmtm -97.25 136.48 37.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.307 -0.87 . . . . 0.0 109.608 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -121.92 116.92 25.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.977 -1.077 . . . . 0.0 111.047 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 66.8 mt -98.76 135.0 21.14 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.746 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 207' ' ' ALA . 27.2 Cg_endo -68.56 115.64 4.01 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.359 1.189 . . . . 0.0 110.406 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 225' ' ' GLU . 94.0 t -99.02 168.31 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.916 . . . . 0.0 110.127 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.569 ' HB2' HG13 ' A' ' 230' ' ' VAL . 13.8 mt-10 -121.51 -171.71 2.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.264 -0.898 . . . . 0.0 110.501 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.79 68.32 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 110.293 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 229' ' ' MET . 10.9 t-20 -162.77 127.68 3.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 110.221 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 55.03 -87.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.443 -0.786 . . . . 0.0 110.475 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.433 ' N ' ' O ' ' A' ' 227' ' ' ASN . 0.6 OUTLIER -149.21 27.92 0.83 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.933 -1.105 . . . . 0.0 110.217 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.611 HG21 ' NH1' ' A' ' 263' ' ' ARG . 84.3 t 53.71 101.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.459 -0.775 . . . . 0.0 110.601 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -53.46 129.61 32.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.927 . . . . 0.0 110.104 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.614 HG21 HG21 ' A' ' 266' ' ' THR . 5.2 tt -101.15 16.93 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.891 . . . . 0.0 110.694 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.4 t -75.33 -5.58 45.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.172 -0.955 . . . . 0.0 110.836 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -100.45 -10.59 20.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.069 -1.019 . . . . 0.0 110.874 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.767 ' HE3' HD11 ' A' ' 267' ' ' ILE . 36.3 m0 -99.53 19.83 15.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.023 -1.048 . . . . 0.0 110.601 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.22 -65.84 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.034 -1.041 . . . . 0.0 109.676 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -64.48 -32.73 74.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 110.213 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 235' ' ' TRP . 9.1 tm-20 -67.42 -49.36 64.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.24 -0.912 . . . . 0.0 110.038 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.679 ' CB ' HG23 ' A' ' 267' ' ' ILE . . . -56.04 -58.76 6.54 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.379 -0.826 . . . . 0.0 111.037 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.957 HG22 ' HA ' ' A' ' 271' ' ' TYR . 1.0 OUTLIER -68.21 -16.68 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.98 . . . . 0.0 111.424 -178.123 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 245' ' ' TRP . . . -87.73 -33.4 11.31 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.742 ' O ' HG23 ' A' ' 246' ' ' VAL . 1.8 m-85 -82.41 -48.14 11.46 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.866 -0.785 . . . . 0.0 109.772 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.939 HD13 HG21 ' A' ' 253' ' ' VAL . 48.4 mm -65.78 -44.15 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.43 -0.793 . . . . 0.0 110.332 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 240' ' ' ILE . 57.1 t0 -68.65 -38.96 80.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.929 -1.107 . . . . 0.0 110.231 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TRP . . . . . 0.427 ' C ' ' CD1' ' A' ' 245' ' ' TRP . 9.6 t-105 -61.52 -28.3 69.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 110.025 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 242' ' ' PHE . 71.4 t -81.2 -40.89 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -0.933 . . . . 0.0 110.548 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.77 -23.69 62.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.943 . . . . 0.0 110.459 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -88.08 -15.54 35.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 0.0 110.737 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 8.3 t -149.99 -49.68 0.14 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.144 -0.972 . . . . 0.0 110.494 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -54.25 -89.97 0.01 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 157.61 -72.63 0.24 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -123.25 130.11 52.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -1.11 . . . . 0.0 110.332 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.939 HG21 HD13 ' A' ' 243' ' ' ILE . 11.7 p -117.65 125.67 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 0.0 110.261 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.453 HD12 ' CB ' ' A' ' 181' ' ' PHE . 0.5 OUTLIER -118.26 119.27 34.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 110.544 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.558 HG12 ' HB3' ' A' ' 264' ' ' SER . 39.8 t -90.17 123.59 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.299 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -87.22 173.02 9.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.502 -0.749 . . . . 0.0 110.602 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 39.5 t -117.08 177.1 4.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 109.997 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.02 21.43 0.44 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 0.0 110.722 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -173.05 29.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 110.677 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 50.74 34.51 29.13 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 263' ' ' ARG . 11.3 tt -117.79 170.4 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -1.125 . . . . 0.0 110.326 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 11.1 m -89.81 19.2 4.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 110.646 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . 0.611 ' NH1' HG21 ' A' ' 230' ' ' VAL . 10.3 ttm180 -51.95 -45.06 64.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.957 . . . . 0.0 110.309 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.558 ' HB3' HG12 ' A' ' 255' ' ' VAL . 4.5 m -60.86 -46.01 92.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.113 -0.992 . . . . 0.0 109.849 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.71 ' HA ' HD22 ' A' ' 182' ' ' LEU . . . -60.6 -26.56 67.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.414 -0.804 . . . . 0.0 109.793 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.614 HG21 HG21 ' A' ' 232' ' ' ILE . 56.0 m -70.39 -38.96 74.78 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.374 -0.829 . . . . 0.0 109.642 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.767 HD11 ' HE3' ' A' ' 235' ' ' TRP . 42.6 mm -60.39 -53.96 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.154 -0.966 . . . . 0.0 109.295 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . 0.703 ' SG ' HD23 ' A' ' 180' ' ' LEU . 38.4 t -56.74 -31.66 64.78 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.19 -0.943 . . . . 0.0 109.363 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.732 HD22 HG21 ' A' ' 287' ' ' VAL . 0.3 OUTLIER -56.87 -47.01 81.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.366 -0.834 . . . . 0.0 109.352 178.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -57.44 -45.31 84.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.341 -0.85 . . . . 0.0 109.601 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.957 ' HA ' HG22 ' A' ' 240' ' ' ILE . 68.0 t80 -54.28 -55.05 32.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.791 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.625 ' O ' HG22 ' A' ' 278' ' ' VAL . 0.1 OUTLIER -61.48 -18.84 60.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 110.428 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' MET . . . . . 0.405 ' SD ' HG11 ' A' ' 311' ' ' VAL . 20.9 mtm -85.04 -58.43 2.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.069 -1.019 . . . . 0.0 110.565 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.532 ' HB2' HG22 ' A' ' 311' ' ' VAL . 4.0 tm0? -73.42 -23.93 60.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.938 . . . . 0.0 110.456 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 271' ' ' TYR . 6.5 t -95.78 -48.26 5.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.597 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 272' ' ' LEU . 4.2 ttt-85 -92.09 -8.9 44.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 111.0 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.426 ' HA ' HD21 ' A' ' 312' ' ' LEU . 2.8 mtt85 52.76 57.7 6.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.006 -1.059 . . . . 0.0 110.621 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.882 HG23 ' HB2' ' A' ' 283' ' ' ALA . 28.5 m -124.22 5.88 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 110.878 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 55.68 165.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.278 -0.889 . . . . 0.0 110.77 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.725 HD12 ' CD2' ' A' ' 307' ' ' PHE . 1.8 tt -61.78 -16.59 50.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.205 -0.935 . . . . 0.0 110.378 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.21 -66.75 0.54 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.153 -0.967 . . . . 0.0 110.579 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLU . . . . . 0.421 ' HB3' ' HB ' ' A' ' 278' ' ' VAL . 1.4 tt0 -74.6 -30.62 61.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 110.22 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.882 ' HB2' HG23 ' A' ' 278' ' ' VAL . . . -63.52 -55.14 26.35 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.178 -0.951 . . . . 0.0 109.964 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 288' ' ' LYS . 15.2 t80 -61.41 -33.07 73.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 110.171 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -72.97 -21.78 60.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 110.471 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.39 -49.84 6.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.905 . . . . 0.0 110.638 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.965 HG13 HD11 ' A' ' 176' ' ' ILE . 98.9 t -51.18 -25.24 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 110.717 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 284' ' ' PHE . 1.7 pttp -171.11 -171.28 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.084 -1.01 . . . . 0.0 110.586 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -94.6 -179.77 4.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 0.0 110.354 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -64.12 -154.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 110.25 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 54.58 95.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.103 -0.998 . . . . 0.0 110.372 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 145.78 72.85 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 56.2 t -109.26 128.33 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -1.144 . . . . 0.0 110.364 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . . . . . . . . . 16.6 pt -91.67 149.39 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.893 . . . . 0.0 110.43 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 54.29 173.83 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.893 . . . . 0.0 110.528 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -63.88 99.8 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.602 1.317 . . . . 0.0 110.447 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -162.38 39.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 110.291 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -91.25 146.3 23.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 110.433 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 12.0 p 48.79 56.26 7.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.873 . . . . 0.0 110.765 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.73 136.42 16.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 110.286 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' MET . . . . . . . . . . . . . 27.6 mtt -124.46 45.59 2.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 110.278 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -95.26 -45.7 2.97 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -63.26 106.39 0.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -1.151 . . . . 0.0 110.502 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.83 -69.2 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 110.187 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.447 HD23 HG23 ' A' ' 309' ' ' THR . 0.6 OUTLIER -65.4 -22.15 66.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.915 . . . . 0.0 110.181 179.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.68 -63.47 1.21 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.875 . . . . 0.0 109.911 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' PHE . . . . . 0.725 ' CD2' HD12 ' A' ' 280' ' ' LEU . 1.3 m-85 -61.64 -34.53 75.86 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.342 -0.849 . . . . 0.0 109.901 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.413 ' HA ' HD13 ' A' ' 312' ' ' LEU . 26.1 tt0 -56.09 -67.99 0.25 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.0 110.235 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.447 HG23 HD23 ' A' ' 305' ' ' LEU . 20.5 p -62.47 -13.73 33.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.091 -1.005 . . . . 0.0 110.849 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -83.2 -45.81 13.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.011 -1.055 . . . . 0.0 110.999 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.829 HG13 HD12 ' A' ' 312' ' ' LEU . 12.0 p -96.98 -31.57 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 111.293 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.829 HD12 HG13 ' A' ' 311' ' ' VAL . 2.4 mp -88.9 -74.37 0.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.947 -1.096 . . . . 0.0 110.386 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' CYS . . . . . . . . . . . . . 32.4 t -50.93 -49.71 59.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.591 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' HIS . . . . . . . . . . . . . 65.7 m80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.403 -179.99 . . . . . . . . 0 0 . 1 stop_ save_